Total Payments
$12,164
2024 Payments
$1,756
Companies
55
Transactions
885
Medicare Patients
2,301
Medicare Billing
$104,593
Payment Breakdown by Category
Food & Beverage$11,958 (98.3%)
Education$206.05 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,958 | 873 | 98.3% |
| Education | $206.05 | 12 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,950 | 193 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,182 | 89 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $813.85 | 41 | $0 (2024) |
| Lilly USA, LLC | $802.10 | 53 | $0 (2024) |
| Amgen Inc. | $653.58 | 41 | $0 (2024) |
| Merck Sharp & Dohme LLC | $652.88 | 54 | $0 (2023) |
| PFIZER INC. | $633.61 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $595.28 | 26 | $0 (2024) |
| ABBVIE INC. | $568.38 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $540.63 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,756 | 90 | ABBVIE INC. ($256.20) |
| 2023 | $2,051 | 128 | Lilly USA, LLC ($303.38) |
| 2022 | $1,348 | 85 | Lilly USA, LLC ($215.46) |
| 2021 | $823.61 | 59 | Novo Nordisk Inc ($262.48) |
| 2020 | $1,110 | 80 | Novo Nordisk Inc ($224.61) |
| 2019 | $1,475 | 120 | Novo Nordisk Inc ($272.86) |
| 2018 | $1,328 | 117 | Novo Nordisk Inc ($315.33) |
| 2017 | $2,271 | 206 | Novo Nordisk Inc ($305.49) |
All Payment Transactions
885 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Oncology | ||||||
| 11/22/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Hematology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Respiratory | ||||||
| 11/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Biological | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Diabetes | ||||||
| 10/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardio-renal | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 267 | 476 | $10,141 | $3,758 |
| 2022 | 7 | 412 | 652 | $25,084 | $10,106 |
| 2021 | 8 | 572 | 861 | $28,352 | $11,365 |
| 2020 | 22 | 1,050 | 1,696 | $178,108 | $79,363 |
Total Patients
2,301
Total Services
3,685
Medicare Billing
$104,593
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 121 | 305 | $7,015 | $2,904 | 41.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 109 | 122 | $2,440 | $746.75 | 30.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 37 | 49 | $686.00 | $107.80 | 15.7% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 23 | 41 | $9,348 | $4,103 | 43.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 133 | 318 | $7,314 | $3,049 | 41.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 25 | 28 | $2,380 | $1,094 | 46.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 116 | 132 | $2,640 | $824.65 | 31.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 18 | 28 | $2,016 | $691.16 | 34.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 28 | 28 | $308.00 | $173.30 | 56.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 69 | 77 | $1,078 | $171.43 | 15.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 137 | 318 | $7,314 | $3,080 | 42.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 43 | $5,547 | $2,382 | 42.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 30 | 36 | $4,212 | $1,893 | 44.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 172 | 220 | $4,400 | $1,416 | 32.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 29 | 42 | $3,024 | $1,276 | 42.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 16 | 17 | $1,445 | $663.23 | 45.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 60 | 60 | $660.00 | $373.80 | 56.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 104 | 125 | $1,750 | $281.25 | 16.1% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 57 | 155 | $35,340 | $15,685 | 44.4% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 65 | 71 | $19,596 | $9,196 | 46.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 57 | 157 | $20,253 | $8,809 | 43.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 28 | 92 | $16,928 | $7,366 | 43.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 34 | 37 | $12,839 | $5,809 | 45.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 48 | 50 | $11,800 | $5,340 | 45.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 166 | 367 | $8,441 | $3,536 | 41.9% |
About Dr. Mohammad Shahzad, M.D
Dr. Mohammad Shahzad, M.D is a Internal Medicine healthcare provider based in Danville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609830462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Shahzad, M.D has received a total of $12,164 in payments from pharmaceutical and medical device companies, with $1,756 received in 2024. These payments were reported across 885 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($11,958).
As a Medicare-enrolled provider, Shahzad has provided services to 2,301 Medicare beneficiaries, totaling 3,685 services with total Medicare billing of $104,593. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Danville, KY
- Active Since 04/17/2006
- Last Updated 07/07/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609830462
Products in Payments
- TRELEGY ELLIPTA (Drug) $771.75
- VRAYLAR (Drug) $604.92
- MOUNJARO (Drug) $467.60
- Saxenda (Drug) $466.41
- Ozempic (Drug) $376.86
- XARELTO (Drug) $360.46
- JANUVIA (Drug) $346.51
- Tresiba (Drug) $344.97
- JARDIANCE (Drug) $311.88
- FARXIGA (Drug) $302.09
- LEQVIO (Drug) $285.07
- BREZTRI (Drug) $257.32
- ENTRESTO (Drug) $255.56
- CHANTIX (Drug) $255.53
- Otezla (Drug) $243.12
- Victoza (Drug) $233.12
- Rybelsus (Drug) $210.68
- ANORO (Drug) $208.39
- TROKENDI XR (Drug) $191.39
- GEMTESA (Drug) $177.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Danville
Dr. Christopher Still, D.o, D.O
Internal Medicine — Payments: $461,951
Internal Medicine $461,951
Dr. Brendan Carry, M.d, M.D
Internal Medicine — Payments: $209,824
Internal Medicine $209,824
Prince Anand, M.d, M.D
Internal Medicine — Payments: $188,555
Internal Medicine $188,555
Jessica Mckee, D.o, D.O
Internal Medicine — Payments: $57,390
Internal Medicine $57,390
Michael Caplan, Md, MD
Internal Medicine — Payments: $41,374
Internal Medicine $41,374
Dr. Mark Reginato, M.d, M.D
Internal Medicine — Payments: $23,997
Internal Medicine $23,997